Is SPRO a buy or a sell?
The Discounted Cash Flow (DCF) valuation of Spero Therapeutics Inc (SPRO) is 5.67 USD. With the latest stock price at 0.82 USD, the upside of Spero Therapeutics Inc based on DCF is 593.0%. This means that SPRO is a buy according to the DCF valuation model.
| Range | Selected | |
| WACC / Discount Rate | 7.4% - 8.9% | 8.2% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 5.13 - 6.41 | 5.67 |
| Upside | 527.0% - 684.3% | 593.0% |